Ashp Advantage's Engaging The Experts

William Zellmer talks with Kevin Garey and Pablo Okhuysen about strategies for prevention and treatment of recurrent Clostridioides difficile infection.

William Zellmer talks with Christine Walko and Shetal Patel about immune checkpoint inhibitors.

In Part 3 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about practical approaches for attaining compliance.

In Part 2 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about changes that may be needed to get your facility ready.

In Part 1 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about key changes to note.

William Zellmer talks with John Petrich and Michael Storey about gene therapies and considerations for integrating them into pharmacy practice.

Angela Cassano talks with Ryan Forrey about insourcing compounded sterile products and how he addressed the challenges faced at Emory University Hospital Midtown.

Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washin

Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washington State University College of Pharmac

In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of Pharmacy President, Hospital and Health System Services Visante, Inc. Ann Arbor, Michigan C.E. Credits: This activity is not eligible for continuing education credits.

In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding biosimilars, focusing on interchangeability and the integration of biosimilars into the medication-use system. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of Pharmacy President, Hospital and Health System Services Visante, Inc. Ann Arbor, Michigan C.E. Credits: This activity is not eligible for continuing education credits.

William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair Assistant Director of Experiential Education Associate Professor Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Curtis L. Triplitt, Pharm.D., CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas C.E. Credits: This activity is not eligible for continuing education credits.

William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair Assistant Director of Experiential Education Associate Professor Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Curtis L. Triplitt, Pharm.D., CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas C.E. Credits: This activity is not eligible for continuing education credits.

William Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care needing improvement. Faculty: Joseph F. Dasta, M.S., MCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Gretchen M. Brophy, Pharm.D., BCPS, FCCP, FCCM, FNCS Professor of Pharmacotherapy & Outcomes Science and Neurosurgery Virginia Commonwealth University Medical College of Virginia Campus Richmond, Virginia C.E. Credits: This activity is not eligible for continuing education credits.

William Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care needing improvement. Faculty: Joseph F. Dasta, M.S., MCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Gretchen M. Brophy, Pharm.D., BCPS, FCCP, FCCM, FNCS Professor of Pharmacotherapy & Outcomes Science and Neurosurgery Virginia Commonwealth University Medical College of Virginia Campus Richmond, Virginia C.E. Credits: This activity is not eligible for continuing education credits.

William Zellmer discusses therapeutic options for treating patients with advanced melanoma with Christine Walko and R. Donald Harvey. They explore the epidemiology of melanoma including risk factors for developing the disease and discuss broad categories of new treatments and specific agents in each category. Faculty: Christine M. Walko, Pharm.D., BCOP, FCCP Clinical Pharmacogenomic Scientist Moffitt Cancer Center Associate Professor University of South Florida Morsani College of Medicine Tampa, Florida R. Donald Harvey, Pharm.D., FCCP, BCOP Associate Professor, Hematology/Medical Oncology Director, Phase 1 Clinical Trials Section Winship Cancer Institute Emory University Atlanta, Georgia C.E. Credits: This activity is not eligible for continuing education credits.

Neil A. Davis is interviewed by John Esterly on the topic of the role of pharmacists in treating acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). The interview was conducted in January 2014. Faculty: Neil A. Davis, Pharm.D. Clinical Pharmacy Coordinator, Critical Care Specialist, and Antibiotic Stewardship Co-chair Sentara Healthcare Virginia Beach, Virginia John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair Assistant Professor, Pharmacy Practice Chicago State University College of Pharmacy Infectious Diseases Pharmacist Northwestern Memorial Hospital Chicago, Illinois C.E. Credits: This activity is not eligible for continuing education credits.

Scott Bergman is interviewed by John Esterly and address controversies and conundrums in the treatment of community-acquired bacterial pneumonia (CABP). The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Scott Bergman, Pharm.D., BCPS (AQ-ID) Associate Professor Southern Illinois University Edwardsville Clinical Pharmacy Specialist and PGY2 Infectious Diseases Residency Program Director St. John’s Hospital Springfield, Illinois John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair Assistant Professor, Pharmacy Practice Chicago State University College of Pharmacy Infectious Diseases Pharmacist Northwestern Memorial Hospital Chicago, Illinois C.E. Credits: This activity is not eligible for continuing education credits.

John Esterly is interviewed by Scott Bergman and discusses considerations for incorporating new acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) treatment options into the pharmacist’s practice. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair Assistant Professor, Pharmacy Practice Chicago State University College of Pharmacy Infectious Diseases Pharmacist Northwestern Memorial Hospital Chicago, Illinois Scott Bergman, Pharm.D., BCPS (AQ-ID) Associate Professor Southern Illinois University Edwardsville Clinical Pharmacy Specialist and PGY2 Infectious Diseases Residency Program Director St. John’s Hospital Springfield, Illinois C.E. Credits: This activity is not eligible for continuing education credits.

Julie Golembiewski conducts a roundtable discussion with Virginia Ghafoor and Leslie Schechter about the use of local anesthetics in managing postoperative pain, focusing on safety and logistical issues related to newer agents. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Julie Golembiewski, Pharm.D., FASHP, Activity Chair Clinical Pharmacist, Anesthesia and Pain University of Illinois Hospital and Health Sciences System Clinical Associate Professor Colleges of Pharmacy and Medicine University of Illinois at Chicago Chicago, Illinois Virginia L. Ghafoor, Pharm.D. Pharmacy Specialist, Pain Management University of Minnesota Medical Center Minneapolis, Minnesota Leslie N. Schechter, Pharm.D. Advanced Practice Pharmacist, Pain Management and Nutritional Support Thomas Jefferson University Hospital Clinical Assistant Professor Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania C.E. Credits: This activity is not eligibl